Paper13680264
Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
Kawai H and 2 others. Arch Gynecol Obstet, 2004. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Papers, record 13680264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13680264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Estrogen Replacement Therapy | Major topic |
| Follicle Stimulating Hormone | Major topic |
| Osteoporosis, Postmenopausal | Major topic |
| Adult | |
| Aged | |
| Biomarkers | |
| Bone Density | |
| Estradiol | |
| Female | |
| Humans | |
| Luteinizing Hormone | |
| Medical Records | |
| Middle Aged | |
| Predictive Value of Tests | |
| Retrospective Studies |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42739753 | Is Follicle-Stimulating Hormone (FSH) Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739753 | PubMed |
| 39633710 | Research progress on FSH-FSHR signaling in the pathogenesis of non-reproductive diseases. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39633710 | PubMed |
| 39394788 | Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/39394788 | PubMed |
| 37914684 | Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets. | Nat Commun | 2023 | https://conductscience.org/library/papers/37914684 | PubMed |
| 37715028 | Pituitary crosstalk with bone, adipose tissue and brain. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/37715028 | PubMed |
| 37455904 | The complications of male hypogonadism: is it just a matter of low testosterone? | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37455904 | PubMed |
| 36692543 | Follicle-stimulating hormone is associated with low bone mass in postmenopausal women. | Osteoporos Int | 2023 | https://conductscience.org/library/papers/36692543 | PubMed |
| 35992104 | FSH and bone: Comparison between males with central versus primary hypogonadism. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35992104 | PubMed |
| 35966744 | Efficacy and Safety of Moxibustion for Menopausal Obesity: A Multicentre, Randomized, Controlled Trial Protocol. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35966744 | PubMed |
| 34948434 | Management of Osteoporosis in Men: A Narrative Review. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948434 | PubMed |
| 30713101 | Sex hormones and stroke: Beyond estrogens. | Horm Behav | 2019 | https://conductscience.org/library/papers/30713101 | PubMed |
| 30275766 | The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen? | Int J Med Sci | 2018 | https://conductscience.org/library/papers/30275766 | PubMed |
| 30085049 | FSH, Bone Mass, Body Fat, and Biological Aging. | Endocrinology | 2018 | https://conductscience.org/library/papers/30085049 | PubMed |
| 29897433 | Regulation of Skeletal Homeostasis. | Endocr Rev | 2018 | https://conductscience.org/library/papers/29897433 | PubMed |
| 29555849 | Actions of pituitary hormones beyond traditional targets. | J Endocrinol | 2018 | https://conductscience.org/library/papers/29555849 | PubMed |
| 28538730 | Blocking FSH induces thermogenic adipose tissue and reduces body fat. | Nature | 2017 | https://conductscience.org/library/papers/28538730 | PubMed |
| 27199891 | Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies. | Front Endocrinol (Lausanne) | 2016 | https://conductscience.org/library/papers/27199891 | PubMed |
| 22561017 | Blocking FSH action attenuates osteoclastogenesis. | Biochem Biophys Res Commun | 2012 | https://conductscience.org/library/papers/22561017 | PubMed |
| 22350658 | Further evidence that FSH causes bone loss independently of low estrogen. | Endocrine | 2012 | https://conductscience.org/library/papers/22350658 | PubMed |
| 20428406 | Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis. | Int J Gen Med | 2008 | https://conductscience.org/library/papers/20428406 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/13680264
GET https://conductscience.org/api/papers/v1/13680264/authors